We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+23.07%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$6.14B
AUM Growth
+$2.32B
Cap. Flow
+$1.46B
Cap. Flow %
23.76%
Top 10 Hldgs %
63.49%
Holding
77
New
9
Increased
16
Reduced
14
Closed
12

Top Buys

Rank Stock Value
1
TLN
Talen Energy Corp
TLN
+$1.6B
2
VST icon
Vistra
VST
+$67.7M
3
UAL icon
United Airlines
UAL
+$51.5M
4
THS
Treehouse Foods
THS
+$45.4M
5
DK icon
Delek US
DK
+$42.3M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$65.8M
2
PLAY icon
Dave & Buster's
PLAY
+$48.8M
3
COOP
Mr. Cooper
COOP
+$42.8M
4
VYX icon
NCR Voyix
VYX
+$42.4M
5
COLL icon
Collegium Pharmaceutical
COLL
+$38.6M

Sector Composition

Rank Sector Weight
1 Utilities 39.48%
2 Healthcare 32.6%
3 Technology 5.2%
4 Industrials 5.14%
5 Energy 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSAT icon
51
Telesat
TSAT
$934M
$12.6M 0.21%
959,764
– –
OABI icon
52
OmniAb
OABI
$497M
$12.1M 0.2%
2,850,588
– –
CHRS icon
53
Coherus Oncology
CHRS
$181M
$10.8M 0.18%
10,400,000
– –
SEG
54
Seaport Entertainment Group
SEG
$373M
$7.59M 0.12%
+276,942
New +$7.88M
ABUS icon
55
Arbutus Biopharma
ABUS
$907M
$6.47M 0.11%
1,681,090
– –
OVID icon
56
Ovid Therapeutics
OVID
$489M
$6.27M 0.1%
5,315,969
– –
IART icon
57
Integra LifeSciences
IART
$1.35B
$5.33M 0.09%
+293,083
New +$6.79M
MYPS icon
58
PLAYSTUDIOS Inc
MYPS
$72.1M
$4.09M 0.07%
2,711,190
– –
ANIP icon
59
ANI Pharmaceuticals
ANIP
$1.73B
$3.38M 0.06%
56,671
-547,129
-91% -$33.4M
HOWL icon
60
Werewolf Therapeutics
HOWL
$18.6M
$2.83M 0.05%
1,333,893
– –
TXMD icon
61
TherapeuticsMD
TXMD
$24.1M
$1.98M 0.03%
1,192,191
– –
SEG.RT
62
DELISTED
Seaport Entertainment Group Inc. Rights (expiring October 10, 2024)
SEG.RT
$426K 0.01%
+144,563
New +$416K
ZVRA icon
63
Zevra Therapeutics
ZVRA
$679M
$139K ﹤0.01%
+20,000
New +$136K
VINC
64
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$83.7K ﹤0.01%
5,844
– –
BCYC
65
Bicycle Therapeutics
BCYC
$284M
– –
-205,423
Closed -$4.16M
CRS icon
66
Carpenter Technology
CRS
$26.3B
– –
-139,806
Closed -$15.3M
IMVT icon
67
Immunovant
IMVT
$8.8B
– –
-58,624
Closed -$1.55M
JAZZ icon
68
Jazz Pharmaceuticals
JAZZ
$16.2B
– –
-616,617
Closed -$65.8M
KOP icon
69
Koppers
KOP
$857M
– –
-361,487
Closed -$13.4M
PLAY icon
70
Dave & Buster's
PLAY
$361M
– –
-1,225,000
Closed -$48.8M
PLYA
71
DELISTED
Playa Hotels & Resorts
PLYA
– –
-1,037,788
Closed -$8.71M
PTGX icon
72
Protagonist Therapeutics
PTGX
$9.84B
– –
-198,059
Closed -$6.86M
SPRY icon
73
ARS Pharmaceuticals
SPRY
$601M
– –
-639,203
Closed -$5.44M
SSTK icon
74
Shutterstock
SSTK
$208M
– –
-381,631
Closed -$14.8M
VYX icon
75
NCR Voyix
VYX
$1.12B
– –
-3,437,030
Closed -$42.4M
1 2
3
4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q3 2024 Portfolio in Review

As of Q3 2024, Rubric Capital Management (New York) held 77 positions worth $6.14B, up 61% from $3.81B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Rubric Capital Management (New York) deployed $1.46B of net new capital in Q3 2024, opening 9 new positions and adding to 16 existing holdings. Its largest new stake was Talen Energy Corp: 11,368,614 shares worth $2.03B.

By sector, the portfolio is most concentrated in Utilities at 39% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Mr. Cooper, an estimated $42.8M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2024 buy was Talen Energy Corp: 11,368,614 shares worth $2.03B.
  • Rubric Capital Management (New York) added most to Vistra in Q3 2024, an estimated $67.7M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2024 reduction was Mr. Cooper, cutting an estimated $42.8M.
  • Rubric Capital Management (New York) fully exited Jazz Pharmaceuticals in Q3 2024, selling an estimated $65.8M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 63% of its $6.14B portfolio in Q3 2024.
  • Rubric Capital Management (New York) opened 9 new positions and closed 12 in Q3 2024.
  • Rubric Capital Management (New York)'s portfolio value rose 61% quarter-over-quarter to $6.14B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2024, filed 13 Nov 2024.